<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02541110</url>
  </required_header>
  <id_info>
    <org_study_id>Obgyn. .</org_study_id>
    <nct_id>NCT02541110</nct_id>
  </id_info>
  <brief_title>Prediction of Preeclampsia &amp; Other Obstetric Complications by Serum Homocysteine &amp; Doppler</brief_title>
  <official_title>Second Trimester Maternal Serum Homocysteine Level &amp; Uterine Artery Doppler for Prediction of Preeclampsia , Intra-Uterine Growth Retardation (IUGR) &amp; Other Obstetric Complications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kasr El Aini Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kasr El Aini Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Second trimester homocysteine &amp; uterine artery doppler will be assessed&amp; the cases will be
      followed up till delivery for development of preeclampsia, IUGR(intra-uterine growth
      retardation) &amp; other obstetric complications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Spontaneous pregnancies with no risk factors will be included. Fasting plasma total
      homocysteine level samples will be collected between 15th &amp; 19th weeks.

      Uterine artery doppler between 18th &amp; 22nd weeks.

      Method 1: Screen positive cases will be considered if homocysteine level above 6.3umol/l

      Method 2: Screen positive cases will be considered if they had bilateral notches and a mean
      resistivity index (RI) above 0.55, or unilateral notches and a mean RI above 0.65, or absence
      of notches and a mean RI above 0.7.

      Method 3: Screen positive cases will be considered if they had bilateral notches and a mean
      RI above 0.55, or unilateral notches and a mean RI above 0.65, or absence of notches and a
      mean RI above 0.7 combined with homocysteine cut off value of 6.3umol / l.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">February 2016</completion_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of pregnants who developed preeclampsia, those who developed IUGR alone and those who developed other obstetric complications as preterm labour and placental abruption</measure>
    <time_frame>4 months</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Preeclampsia</condition>
  <condition>IUGR</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Spontaneous pregnancies with no risk factors
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  spontaneous pregnancies with no risk factors

        Exclusion Criteria:

          -  multiple pregnancies

          -  non intact renal function

          -  hypertension

          -  diabetes

          -  folic acid supplements

          -  antifolate drugs
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>suzy abdelaziz, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>kasrelaini hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>suzy abdelaziz, M.D.</last_name>
    <phone>01003726195</phone>
    <email>suzyabdelaziz92@gmail.com</email>
  </overall_contact>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 31, 2015</study_first_submitted>
  <study_first_submitted_qc>September 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 4, 2015</study_first_posted>
  <last_update_submitted>September 3, 2015</last_update_submitted>
  <last_update_submitted_qc>September 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 4, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kasr El Aini Hospital</investigator_affiliation>
    <investigator_full_name>suzy abdelaziz Abdelhamid</investigator_full_name>
    <investigator_title>lecturer of Obgyn</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pre-Eclampsia</mesh_term>
    <mesh_term>Fetal Growth Retardation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

